Travera, Inc.
Biotechnology company · Medford, Massachusetts, United States
Travera, Inc. is a biotechnology company headquartered in Medford, Massachusetts, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $224,410 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2021.
Travera at a glance
What does Travera do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $224,410 in total (2019). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $4 million sold (2021).
Frequently asked questions about Travera
Where is Travera headquartered?
Travera, Inc. is headquartered in Medford, Massachusetts, United States.
What does Travera do?
Travera, Inc. is a biotechnology company.
When was Travera founded?
The earliest incorporation on record for Travera, Inc. is in 2017, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.